MedPath

To study the effect of EPIPHEGUS VIRGINIANA versus homoeopathic constitutional medicine in reducing pain of migraine.

Phase 3
Conditions
Health Condition 1: G43- Migraine
Registration Number
CTRI/2023/11/060013
Lead Sponsor
Dr. Akshaya Sebastian
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of age 15- 55 years.

2.Both males and females.

3.Cases which fulfil the international headache society criteria for migraine.

Exclusion Criteria

1. Patients with other primary headaches (cluster headache, tension headache).

2. Patients with secondary headache.

3. Patients with red flags associated with headache.

4. Women who are pregnant and breastfeeding.

5. Persons with cognitive impairment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessed by considering difference in severity of headache <br/ ><br>using HIT-6 Scoring. Difference between before and after Headache Impact Test-6 score after each intervensionTimepoint: Assessed by considering severity of headache <br/ ><br>using HIT-6 Score of each case reviewed at 3-4 weeks up to 3 months.
Secondary Outcome Measures
NameTimeMethod
Comparison of headache impact test-6 scoring between groups receiving epiphegus virginiana and homoeopathic constitutional medicine.Timepoint: Each case reviewed at 3-4 weeks followed up to 3 months
© Copyright 2025. All Rights Reserved by MedPath